Clinical Trial Update: Explore the Efficacy and Safety of edoxabaN in Patients After Heart Valve Repair or Bioprosthetic vaLve Replacement (ENAVLE Trial) [Phase 3]

View source ↗

Summary

Phase 3 trial exploring edoxaban in patients after mitral valve repair or bioprosthetic valve replacement has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Bioprosthetic Mitral Valve Replacement
• Mitral Valve Disease
• Mitral Valve Repair

Drugs mentioned

• Edoxaban (edoxaban)

Snippet

Sponsor: Yonsei University | Conditions: MV(Mitral Valve) Repair | Phase 3 | Status: COMPLETED